What is LumiGenics?
LumiGenics LLC operates as a Contract Research Organization (CRO) with a specialized focus on preclinical optical imaging. The company provides advanced imaging solutions designed to accelerate and improve research and development processes within the life sciences. Its services are tailored for pharmaceutical companies, biotechnology firms, and academic institutions that require cutting-edge imaging technologies for preclinical studies, aiming to enhance drug development outcomes and research efficacy.
How much funding has LumiGenics raised?
LumiGenics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in LumiGenics
PPP
Public-Private Partnership
What's next for LumiGenics?
The substantial late-stage investment LumiGenics has received signals a strong confidence from stakeholders in its business model and future growth potential. This capital infusion is likely to be strategically deployed towards expanding its service offerings, enhancing its technological capabilities in preclinical optical imaging, and potentially broadening its client base. The company is well-positioned to capitalize on the increasing demand for sophisticated preclinical research tools in the pharmaceutical and biotech industries, driving innovation and supporting the development of new therapeutics.
See full LumiGenics company page
